1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsGrants for Behavioral Health Services is sponsored by Ohio Department of Behavioral Health. The Ohio Department of Behavioral Health administers grants and other opportunities to community providers, nonprofits, local Alcohol, Drug Addiction, and Mental Health (ADAMH) Boards, and similar eligible community organizations that promote and provide treatment, prevention, a…
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Community providers, nonprofits, local Alcohol, Drug Addiction, and Mental Health (ADAMH) Boards, and similar eligible community organizations in Ohio that promote and provide treatment, prevention, and recovery service…. Confirm the full requirements in the official notice before applying.
Grants for Behavioral Health Services is funded by Ohio Department of Behavioral Health. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Ohio. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
BJA opened five FY2026 competitions covering reentry, family-based substance use treatment, opioid response and crisis stabilization, with award ceilings from $1 million to $3 million. Grants.gov closes September 24 and 25; JustGrants closes October 1 and 2. The seven-day gap between them is the single most common reason a finished DOJ application never gets reviewed.
Read articleARPA-H selected 13 research teams for EVIDENT, a $139.4M initiative to develop objective clinical endpoints for rapid-acting behavioral health therapies including psilocybin. At least $50M will match state psychedelic research investments under a Trump executive order.
Read articleARPA-H's $139.4M EVIDENT initiative selects 13 research teams to build objective biomarkers for psilocybin, neuromodulation, and rapid-acting mental health therapies.
Read article